XENIKOS BV
EIC Accelerator Winner From 2022
Modulatory immunotherapy for severe immune disease
Netherlands
Articles
EIC Accelerator Funding Insights and Developments for XENIKOS BV
NetherlandsEIC Accelerator2022
Read ArticleModulatory immunotherapy for severe immune disease